Evaluation of the Efficacy and Safety of Midline Venous Catheters

NCT05835531 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2023-04-28

No results posted yet for this study

Summary

Central venous catheters are fundamental tools in medical practice, but their use carries frequent local and systemic complications, with bloodstream infection (bacteremia) and thrombus formation being the most frequent and serious. Both complications prolong hospitalization time, increase morbidity, mortality, and hospital costs. Medium access peripheral venous catheters (MC) are a low-cost, easy-to-place, and highly-durable option that offers greater patient comfort and less pain, among other advantages. The objective of this study is to determine if the implementation of a team specialized in the placement of midline (CM) catheters reduces the incidence of infections associated with central venous catheters, decreases the cost of hospitalization, and preserves venous capital in patients admitted to ICU.

Conditions

  • Midline Catheter

Interventions

DEVICE

Catheters comparation

Assessment of incidence of complications associated with midline catheters

Sponsors & Collaborators

  • Hospital El Cruce

    lead OTHER

Principal Investigators

  • Maximiliano Paz, BSN · Hospital El Cruce

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-20
Primary Completion
2023-05-30
Completion
2023-06-30

Countries

  • Argentina

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05835531 on ClinicalTrials.gov